| abstract |
A pharmaceutical composition for inhibiting amyloid beta peptide in a subject includes a compound having the formula (I): n n n n n n n n n n n n where M is selected from a substituted or unsubstituted alkyl, halo, alkoxy, aryl, cyclic, or heterocyclic group; n p is an integer from 0-3; n X 1 is a 3-9 atoms in length linker connecting A and B; n B is selected from a substituted or unsubstituted aryl, alkoxy or amine group; and n a pharmaceutically acceptable salt thereof; and a pharmaceutical carrier. |